Gentian Diagnostics ASA – Application for admission to trading on Oslo Børs

10. May 2021 | 1 min read

Moss, 7 May 2021

Gentian Diagnostics ASA (the "Company") is pleased to announce that it has today
submitted an application for admission to trading on Oslo Børs by transfer of
its current admission to trading on Euronext Growth operated by Oslo Børs.

Subject to Oslo Børs' approval of the Company's admission application and
satisfaction of any conditions for admission to trading set by Oslo Børs, the
Company expects that the first day of trading of the Company's shares on Oslo
Børs will be in the end for June 2021.

For further information, please contact:

Hilja Ibert CEO, Gentian Diagnostics
E-mail: hilja.ibert@gentian.no 
Cell Phone: +47 919 05 242

Njaal Kind CFO, Gentian Diagnostics
E-mail: njaal.kind@gentian.no 
Cell Phone. +47 919 06 525

You may also read


Jun 18, 2021 - Kristin Hart

Gentian Diagnostics: Invitation to virtual presentation at 24 June

Gentian Diagnostics ASA has the pleasure of inviting to a virtual presentation on Thursday 24 June 2021 at..

Jun 18, 2021 - Kristin Hart

Gentian Diagnostics: A long-term revenue ambition of NOK 1 billion from a portfolio of high-impact diagnostic tests

Moss, 18.06.2021 Gentian Diagnostics ASA, is a fast-growing developer and manufacturer of innovative and..

May 10, 2021 - Kristin Hart

Gentian Diagnostics ASA – Application for admission to trading on Oslo Børs

Moss, 7 May 2021 Gentian Diagnostics ASA (the "Company") is pleased to announce that it has today submitted..